Sequential cytoreductive intervention for cholangiocarcinoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 Dec 2025: Trial registered, NCT07282912
  2. 2 Jun 2026: Trial started, NCT07282912

The trials

NCT07282912: Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

State
Under way
Phase
Phase 2
People
54 planned
Started
2 Jun 2026
Primary completion
Jun 2028
Arms
Sequential cytoreductive intervention
Results
None posted
  1. 15 Dec 2025: Trial registered
  2. 2 Jun 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Surgery or procedure.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.